Literature DB >> 20512433

The experimental design as practical approach to develop and optimize a formulation of peptide-loaded liposomes.

Emilie Ducat1, Michael Brion, Frederic Lecomte, Brigitte Evrard, Geraldine Piel.   

Abstract

To investigate the encapsulation of Print 3G, a peptidic agent that could reduce the angiogenic development of breast tumors, pegylated liposomes used as intravenous vectors were studied and characterized. Recently, the path of liposomes has been explored with success to improve the pharmacological properties of peptidic drugs and to stabilize them. In this study, loaded unilamellar vesicles composed of SPC:CHOL:mPEG2000-DSPE (47:47:6) were prepared by the hydration of lipid film technique. An HPLC method was developed and validated for the determination of Print 3G to calculate its encapsulation efficiency. Observed Print 3G adsorption on different materials employed during liposome preparation (such as glass beads, tubing, and connections for extrusion) led to the modification of the manufacturing method. The freeze-thawing technique was used to enhance the amount of Print 3G encapsulated into blank liposomes prepared using the hydration of lipid film procedure. Many factors may influence peptide entrapment, namely the number of freeze-thawing cycles, the lipid concentration, the peptide concentration, and the mixing time. Consequently, a design of experiments was performed to obtain the best encapsulation efficiency while minimizing the number of experiments. The lipid concentration and the number of freeze-thawing cycles were identified as the positive factors influencing the encapsulation. As a result of the optimization, an optimum was found and encapsulation efficiencies were improved from around 30% to 63%. Liposome integrity was evaluated by photon correlation spectroscopy and freeze-fracture electron microscopy to ensure that the selected formulation possesses the required properties to be a potential candidate for further in vitro and in vivo experiments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512433      PMCID: PMC2902352          DOI: 10.1208/s12249-010-9463-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

Review 1.  Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry.

Authors:  Harald John; Michael Walden; Sandra Schäfer; Sandra Genz; Wolf-Georg Forssmann
Journal:  Anal Bioanal Chem       Date:  2003-11-28       Impact factor: 4.142

2.  Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface.

Authors:  Holger Grohganz; Matthias Rischer; Martin Brandl
Journal:  Eur J Pharm Sci       Date:  2004-02       Impact factor: 4.384

3.  Factors influencing cryoprotective activity and drug leakage from liposomes after freezing.

Authors:  J Higgins; N A Hodges; C J Olliff; A J Phillips
Journal:  J Pharm Pharmacol       Date:  1986-04       Impact factor: 3.765

4.  Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

Authors:  Nancy Dos Santos; Christine Allen; Anne-Marie Doppen; Malathi Anantha; Kelly A K Cox; Ryan C Gallagher; Goran Karlsson; Katarina Edwards; Gail Kenner; Lacey Samuels; Murray S Webb; Marcel B Bally
Journal:  Biochim Biophys Acta       Date:  2007-01-03

Review 5.  Angiogenesis in cancer and other diseases.

Authors:  P Carmeliet; R K Jain
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

6.  Passive adsorption of immunologically active and inactive synthetic peptides to polystyrene is influenced by the proportion of non-polar residues in the peptide.

Authors:  M Sällberg; M Blixt; Z X Zhang; J Ekstrand
Journal:  Immunol Lett       Date:  1995-05       Impact factor: 3.685

Review 7.  Mechanisms and future directions for angiogenesis-based cancer therapies.

Authors:  Frank A Scappaticci
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

8.  Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect.

Authors:  Junko Hanato; Kazuki Kuriyama; Takahiro Mizumoto; Kazuhiro Debari; Junya Hatanaka; Satomi Onoue; Shizuo Yamada
Journal:  Int J Pharm       Date:  2009-08-19       Impact factor: 5.875

Review 9.  Antiangiogenic strategies, compounds, and early clinical results in breast cancer.

Authors:  Alessandro Morabito; Roberta Sarmiento; Paola Bonginelli; Giampietro Gasparini
Journal:  Crit Rev Oncol Hematol       Date:  2004-02       Impact factor: 6.312

10.  Characterizing the freezing behavior of liposomes as a tool to understand the cryopreservation procedures.

Authors:  Lee Fong Siow; Thomas Rades; Miang Hoong Lim
Journal:  Cryobiology       Date:  2007-08-24       Impact factor: 2.487

View more
  7 in total

1.  Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide.

Authors:  Hassan Bardania; Seyed Abbas Shojaosadati; Farzad Kobarfard; Farid Dorkoosh
Journal:  Iran J Biotechnol       Date:  2016-06       Impact factor: 1.671

Review 2.  Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.

Authors:  Vibhuti Agrahari; Vivek Agrahari; Ashim K Mitra
Journal:  Ther Deliv       Date:  2016

Review 3.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

4.  The comparison of protein-entrapped liposomes and lipoparticles: preparation, characterization, and efficacy of cellular uptake.

Authors:  Wei-Kuo Chang; Yu-Ju Tai; Chiao-Hsi Chiang; Chieh-Shen Hu; Po-Da Hong; Ming-Kung Yeh
Journal:  Int J Nanomedicine       Date:  2011-10-20

5.  Optimization of a Method to Prepare Liposomes Containing HER2/Neu- Derived Peptide as a Vaccine Delivery System for Breast Cancer.

Authors:  Sheyda Shariat; Ali Badiee; Mahmoud Reza Jaafari; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

6.  Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size.

Authors:  Farhad Kiafar; Mohammad Reza Siahi Shadbad; Hadi Valizadeh
Journal:  Bioimpacts       Date:  2016-12-29

7.  Formulations, hemolytic and pharmacokinetic studies on saikosaponin a and saikosaponin d compound liposomes.

Authors:  Guo-Song Zhang; Peng-Yi Hu; Dong-Xun Li; Ming-Zhen He; Xiao-Yong Rao; Xiao-Jian Luo; Yue-Sheng Wang; Yu-Rong Wang
Journal:  Molecules       Date:  2015-04-03       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.